Product Comparison


 

No Image

Merck 00006412102 Merck 00006483703 Merck 00006404741 Merck 00006489700
McKesson # 1018475 952614 911398 544446 357993
Description RACK, TEST TUBE TEST N' TOSS DISP 16X100MM (10/CS) Gardasil® 9 Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free 20 mcg - 60 mcg / 0.5 mL Injection 0.5 mL Pneumovax® 23 Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection 0.5 mL RotaTeq® Rotavirus Vaccine, Live, Oral Pentavalent Solution 2 mL PedvaxHIB® Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) 7.5 mcg / 0.5 mL Injection 0.5 mL
Manufacturer # 1871000006412102000064837030000640474100006489700
Brand  Gardasil® 9Pneumovax® 23RotaTeq®PedvaxHIB®
Manufacturer WHITNEY MEDICALMerckMerckMerckMerck
Invoice RACK, TEST TUBE TEST N' TOSS DISP 16X100MM (10/CS)GARDASIL 9 HPV VACC, SYR 0.5ML(10/BX)PNEUMOVAX, SYR 0.5ML (10/CT)ROTATEQ VAC, SUSP 2ML LIVE PENTAV (10/PK)PEDVAXHIB, VL 0.5ML (10/BX)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Application Human Papillomavirus Vaccine (HPV)Pneumonia VaccineRotavirus VaccineHaemophilus Influenzae Type b Vaccine (Hib)
Container Type Prefilled SyringePrefilled SyringeSingle-Dose TubeSingle-Dose Vial
Country of Origin UnknownUnited StatesUnited StatesUnited StatesUnited States
Dosage Form InjectionInjectionSolutionInjection
Generic Drug Code 37568438592650099344
Generic Drug Name Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative FreePneumococcal 23 Vaccine PolyvalentRotavirus Vaccine, Live, Oral PentavalentHaemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)
NDC Number 00006412102000064837030000640474100006489700
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Strength 20 mcg - 60 mcg / 0.5 mL25 mcg / 0.5 mL7.5 mcg / 0.5 mL
Type IntramuscularIntramuscular or SubcutaneousOralIntramuscular
UNSPSC Code 51201649512016155120161851201627
User Indicated for People 9 to 45 Years of AgeIndicated for People 50 Years of Age and OlderIndicated for People 6 to 32 Weeks of AgeIndicated for People 2 to 71 Months of Age
Volume 0.5 mL0.5 mL2 mL0.5 mL
Features and Benefits
  • GARDASIL 9 is a non-infectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58
  • Each 0.5-mL dose contains approximately 30 mcg of HPV Type 6 L1 protein, 40 mcg of HPV Type 11 L1 protein, 60 mcg of HPV Type 16 L1 protein, 40 mcg of HPV Type 18 L1 protein, 20 mcg of HPV Type 31 L1 protein, 20 mcg of HPV Type 33 L1 protein, 20 mcg of HPV Type 45 L1 protein, 20 mcg of HPV Type 52 L1 protein, and 20 mcg of HPV Type 58 L1 protein
  • Administer GARDASIL 9 intramuscularly as a 0.5-mL dose at the following schedule: 0, 2 months, 6 months
  • Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL 9 protects only against those vulvar, vaginal, and anal cancers caused by HPV 16, 18, 31, 33, 45, 52 and 58
  • PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine
  • PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease
  • Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons
  • Store unopened and opened vials at 2° - 8°C (36° - 46°F)
  • The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
  • 10 individually pouched single dose tubes
  • Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
  • Each 0.5 mL dose of Liquid PedvaxHIB is a sterile product formulated to contain: 7.5 mcg of Haemophilus b PRP, 125 mcg of Neisseria meningitidis OMPC and 225 mcg of aluminum as amorphous aluminum hydroxyphosphate sulfate (previously referred to as aluminum hydroxide), in 0.9% sodium chloride, but does not contain lactose or thimerosal